Carcinogenic activities of potassium 1-methyl-7-[2-(5-nitro-2-furyl)vinyl]-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylate (NFN) and 1-ethyl-7-methyl-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid (nalidixic acid) were examined histopathologically using 134 ICR/JCL mice. NFN was fed to 60 mice evenly divided by sex at a dose level of 0.02% by weight for 9 weeks, followed by 5 weeks of basal diet, 0.01% for 7 weeks and 15 weeks of basal diet, with mean cumulative doses of 115mg in males and 125mg in females (Group A). Forty control mice received only basal diet for 36 weeks and were evaluated. Because of suddenly occurred gastric hemorrhage after 7 weeks, 20 mice in Group A survived 20 weeks or longer and were evaluated. Then, 14 mice were supplementally fed 0.015% dose level of NFN for 26 weeks, followed by 10 weeks of basal diet (Group B).
Papillary growths with hyperkeratosis in the squamous epithelium of the forestomach were observed in most of the treated mice and became marked with progress of the experiment. Squamous cell carcinomas of the forestomach were induced in 6 mice (1 male and 5 females) out of 14 Group A animals surviving 31 weeks or longer, but no tumor was produced in the glandular stomach. Pulmonary adenomas, often multifocal, were induced in 19 mice after 21 weeks with one exception. Other tumors also noted were 1 lymphatic leukemia, 1 subcutaneous fibroma, and 1 uterine myosarcoma in Group A, and 1 squamous cell carcinoma of the forestomach, 8 lung adenomas and 2 lung adenocarcinomas, and 2 lymphatic leukemia out of 10 mice surviving 16 weeks or longer in Group B.
Nalidixic acid was fed to 20 mice at a dose level of 0.05% for 36 weeks throughout. No tumor or tumorigenic alteration was induced in any organs, except for 1 hepatic adenoma.
In control group, 1 pulmonary adenoma and 1 lymphatic leukemia were detected during the 36-week period of observation.
抄録全体を表示